Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 143

1.

Results of adjuvant FOLFOX regimens in stage III colorectal cancer patients: retrospective analysis of 667 patients.

Uncu D, Aksoy S, Çetin B, Yetişyiğit T, Özdemir N, Berk V, Dane F, Inal A, Harputluoğlu H, Budakoğlu B, Koca D, Sevinç A, Cihan S, Durnalı AG, Özkan M, Öztürk MA, Işıkdoğan A, Büyükberber S, Benekli M, Köş T, Alkış N, Karaca H, Turhal NS, Zengin N; Anatolian Society of Medical Oncology.

Oncology. 2013;84(4):240-5. doi: 10.1159/000336902. Epub 2013 Feb 7.

PMID:
23392240
[PubMed - indexed for MEDLINE]
2.

Adjuvant modified FOLFOX-4 in patients with stage III rectum adenocarcinoma.

Cihan Ş, Uncu D, Babacan NA, Özdemir N, Odabaş H, Aksoy S, Öksüzoğlu B, Zengin N.

Asian Pac J Cancer Prev. 2011;12(4):967-70.

PMID:
21790235
[PubMed - indexed for MEDLINE]
Free Article
3.

Evaluation of oxaliplatin dose intensity in bimonthly leucovorin and 48-hour 5-fluorouracil continuous infusion regimens (FOLFOX) in pretreated metastatic colorectal cancer. Oncology Multidisciplinary Research Group (GERCOR).

Maindrault-Goebel F, de Gramont A, Louvet C, André T, Carola E, Gilles V, Lotz JP, Tournigand C, Mabro M, Molitor JL, Artru P, Izrael V, Krulik M.

Ann Oncol. 2000 Nov;11(11):1477-83.

PMID:
11142489
[PubMed - indexed for MEDLINE]
Free Article
4.

Adjuvant FOLFOX chemotherapy and splenomegaly in patients with stages II-III colorectal cancer.

Angitapalli R, Litwin AM, Kumar PR, Nasser E, Lombardo J, Mashtare T, Wilding GE, Fakih MG.

Oncology. 2009;76(5):363-8. doi: 10.1159/000210025. Epub 2009 Mar 25.

PMID:
19321964
[PubMed - indexed for MEDLINE]
5.

The efficacy and toxicity of FOLFOX regimen (a combination of leucovorin and fluorouracil with oxaliplatin) as first-line treatment of metastatic colorectal cancer.

Matsushita H, Tsuboi K, Honda I, Kato N, Okochi O, Kobayashi D, Hattori M.

Gan To Kagaku Ryoho. 2009 May;36(5):797-801.

PMID:
19461180
[PubMed - indexed for MEDLINE]
6.

A Phase II study of oxaliplatin with low-dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFOX-4) for gastric cancer patients with malignant ascites.

Oh SY, Kwon HC, Lee S, Lee DM, Yoo HS, Kim SH, Jang JS, Kim MC, Jeong JS, Kim HJ.

Jpn J Clin Oncol. 2007 Dec;37(12):930-5. doi: 10.1093/jjco/hym131.

PMID:
18211984
[PubMed - indexed for MEDLINE]
Free Article
7.

[Clinical significance of bolus 5-fluorouracil for recurrent or metastatic colorectal cancer treated with FOLFOX+ BevacizumabTherapy].

Yoshida Y, Hasegawa J, Nishimura J, Hirota M, Kim Y, Nezu R.

Gan To Kagaku Ryoho. 2011 Aug;38(8):1293-6. Japanese.

PMID:
21829066
[PubMed - indexed for MEDLINE]
8.

Feasibility of mFOLFOX6 as the adjuvant treatment after curative resection of metastases from colorectal cancer in Japanese patients.

Machida N, Yoshizaki K, Boku N, Yamazaki K, Onozawa Y, Fukutomi A, Yasui H, Taku K.

Int J Clin Oncol. 2013 Apr;18(2):279-84. doi: 10.1007/s10147-012-0374-z. Epub 2012 Feb 25.

PMID:
22367535
[PubMed - indexed for MEDLINE]
9.

[FOLFOX regimen in the patients with locally advanced or metastatic gastric cancer].

Yan D, Dai H.

Zhonghua Zhong Liu Za Zhi. 2009 Mar;31(3):217-9. Chinese.

PMID:
19615264
[PubMed - indexed for MEDLINE]
10.

How do we apply adjuvant FOLFOX to Japanese patients with curatively resected colorectal cancer?

Suenaga M, Matsusaka S, Watanabe T, Kuboki Y, Shinozaki E, Chin K, Mizunuma N, Ueno M, Yamaguchi T, Hatake K.

Asia Pac J Clin Oncol. 2011 Jun;7(2):129-35. doi: 10.1111/j.1743-7563.2011.01385.x.

PMID:
21585692
[PubMed - indexed for MEDLINE]
11.

Intensive systemic chemotherapy combined with surgery for metastatic colorectal cancer: results of a phase II study.

Taïeb J, Artru P, Paye F, Louvet C, Perez N, André T, Gayet B, Hebbar M, Goebel FM, Tournigand C, Parc R, de Gramont A.

J Clin Oncol. 2005 Jan 20;23(3):502-9.

PMID:
15659495
[PubMed - indexed for MEDLINE]
12.

A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.

Goldberg RM, Sargent DJ, Morton RF, Fuchs CS, Ramanathan RK, Williamson SK, Findlay BP, Pitot HC, Alberts SR.

J Clin Oncol. 2004 Jan 1;22(1):23-30. Epub 2003 Dec 9.

PMID:
14665611
[PubMed - indexed for MEDLINE]
13.

Two different first-line 5-fluorouracil regimens with or without oxaliplatin in patients with metastatic colorectal cancer.

Cunningham D, Sirohi B, Pluzanska A, Utracka-Hutka B, Zaluski J, Glynne-Jones R, Koralewski P, Bridgewater J, Mainwaring P, Wasan H, Wang JY, Szczylik C, Clingan P, Chan RT, Tabah-Fisch I, Cassidy J.

Ann Oncol. 2009 Feb;20(2):244-50. doi: 10.1093/annonc/mdn638. Epub 2008 Oct 14.

PMID:
18854549
[PubMed - indexed for MEDLINE]
Free Article
14.

[Clinical observation of XELOX (Capecitabine puls Oxaliplatin): an adjuvant chemotherapy regimen used in stage III colorectal cancer].

Diao C, Cheng RC, Zhang JM, Wei XP, Su YJ, Liu QY, Xu JB.

Zhonghua Zhong Liu Za Zhi. 2008 Feb;30(2):147-50. Chinese.

PMID:
18646702
[PubMed - indexed for MEDLINE]
15.

A meta-analysis of chemotherapy regimen fluorouracil/leucovorin/oxaliplatin compared with fluorouracil/leucovorin in treating advanced colorectal cancer.

Chen ML, Fang CH, Liang LS, Dai LH, Wang XK.

Surg Oncol. 2010 Mar;19(1):38-45. doi: 10.1016/j.suronc.2009.02.015. Epub 2009 Apr 2.

PMID:
19345093
[PubMed - indexed for MEDLINE]
16.

Oxaliplatin/fluorouracil/leucovorin (FOLFOX4 and modified FOLFOX6) in patients with refractory or advanced colorectal cancer: post-approval Japanese population experience.

Shimizu T, Satoh T, Tamura K, Ozaki T, Okamoto I, Fukuoka M, Nakagawa K.

Int J Clin Oncol. 2007 Jun;12(3):218-23. Epub 2007 Jun 27.

PMID:
17566846
[PubMed - indexed for MEDLINE]
17.

A phase II trial of modified FOLFOX as first-line chemotherapy in advanced colorectal cancer.

Xiong JP, Zhang L, Zhong LX, Qiu F, Xu J, Tao QS, Xiang XJ, Yu F, Tang XM.

Anticancer Drugs. 2007 Oct;18(9):1103-7.

PMID:
17704661
[PubMed - indexed for MEDLINE]
18.

Adjuvant oxaliplatin- or irinotecan-containing chemotherapy improves overall survival following resection of metachronous colorectal liver metastases.

Liu JH, Hsieh YY, Chen WS, Hsu YN, Chau GY, Teng HW, King KL, Lin TC, Tzeng CH, Lin JK.

Int J Colorectal Dis. 2010 Oct;25(10):1243-9. doi: 10.1007/s00384-010-0996-4. Epub 2010 Jun 24.

PMID:
20574727
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Oxaliplatin, folinic acid and 5-fluorouracil (FOLFOX-4) combination chemotherapy as second-line treatment in advanced colorectal cancer patients with irinotecan failure: a Korean single-center experience.

Park SH, Sung JY, Han SH, Baek JH, Oh JH, Bang SM, Cho EK, Shin DB, Lee JH.

Jpn J Clin Oncol. 2005 Sep;35(9):531-5. Epub 2005 Jul 18.

PMID:
16027146
[PubMed - indexed for MEDLINE]
Free Article
20.

Oxaliplatin and protracted venous infusion of 5-fluorouracil in patients with advanced or relapsed 5-fluorouracil pretreated colorectal cancer.

Chau I, Webb A, Cunningham D, Hill M, Waters JS, Norman A, Massey A.

Br J Cancer. 2001 Nov 2;85(9):1258-64.

PMID:
11720458
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk